Friday
11.15.2019
11:16 AM
Login form
Search
Calendar
«  February 2014  »
SuMoTuWeThFrSa
      1
2345678
9101112131415
16171819202122
232425262728
Entries archive

My site

Main » 2014 » February » 19
ME Newswire / Businesswire

SEOUL - Wednesday, February 19th 2014

Stem cell research institute of STC Life Co., Ltd. (Chairman: KYE HO LEE) and 97.7 B&H Clinic (Director: WON JU JUNG) successfully completed mesenchymal stem cell therapy for the patients with Parkinson’s disease, a chronic progressive degenerative disease in nervous system.

Parkinson’s disease is caused when dopamine nerve cells distributed in substance nigra become gradually extinct. It is a chronic progressive degenerative disease characteristically showing quiver, stiffness, bradykinesia and postural instability. General medicine treatment has no effect on Parkinson’s disease and there are no other treatments for it.

97.7 B&H Clinic (Representative Director: WON JU JUNG, www.977bnh.com) administered stem cell into vein of the patients with Parkinson’s disease 3 times every 2 weeks. Mesenchymal stem cell, one of the adult stem cells, is used a lot for neogenesis, and stem cell resea ... Read more »
Views: 56 | Added by: africa-live | Date: 02.19.2014

SAN DIEGO. - Tuesday, February 18th 2014 [ME NewsWire]

(BUSINESS WIRE) Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA InsightSM, the company’s premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient’s risk of developing certain types of cancer.

"We are committed to providing valuable tools to help physicians further improve the quality of health care,” said David Becker, Ph.D., Pathway Genomics’ chief scientific officer. "Our new hereditary colorectal cancer genetic test is part of this commitment as it empowers physicians by providing useful information about cancer risk.”

The American Cancer Society estimates 140,000 colorectal cancer cases in the U.S. in 2013. Additional ... Read more »
Views: 92 | Added by: uaeonlinenews | Date: 02.19.2014

Mobile World Congress 2014

COLOMBES, France - Tuesday, February 18th 2014 [ME NewsWire]

(BUSINESS WIRE)-- Oberthur Technologies, a world leader in digital security solutions for the mobility space, today announced that in1SIM, the global M2M connectivity supplier and a subsidiary of Siptronix, has selected its M-Connect solution to offer optimum mobile connectivity to M2M players.

Together the two companies answer the need for a global and reliable solution to connect smart objects to mobile networks. OT’s M-Connect solution has been designed, in line with the current GSMA standardization, to securely activate and change subscriptions in these objects remotely. It will enable in1SIM to download the best mobile subscription and to switch to an available network in case of loss of connectivity.

The first market trials are planned this year with energy distribution companies in Northern Europe. According to Machina Research, the total number of connected device ... Read more »
Views: 97 | Added by: uaeonlinenews | Date: 02.19.2014 | Comments (0)